Cerebral Infections

  • David Mikulis
  • Stephan Wetzel


The broad categories of infectious diseases that affect the brain continue to present diagnostic challenges. Although imaging patterns of disease are well-established, overlap between categories can occur. For example, the differentiation of cycticercosis, a parasitic infection, from a tuberculous abscess, a bacterial infection, can be difficult. Additional challenges are posed by the increasing probability of encountering nonendemic pathogens secondary to the “globalization” of infections brought on by the expansion of international travel, transportation, and immigration. Furthermore, increasing numbers of individuals are undergoing treatments and therapies that compromise the immune system, leading to altered host responses that no longer express the expected patterns of tissue injury.


Apparent Diffusion Coefficient West Nile Virus Brain Abscess West Nile Virus Infection Cerebral Infection 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Haimes AB, Zimmerman RD, Morgello S et al (1989) MR imaging of brain abscesses. AJR Am J Roentgenol 152:1073–1085PubMedGoogle Scholar
  2. 2.
    Mishra AM, Gupta RK, Saksena S et al (2005) Biological correlates of diffusivity in brain abscess. Magn Reson Med 54:878–885PubMedCrossRefGoogle Scholar
  3. 3.
    Duprez TP, Cosnard G, Hernalsteen D (2005) Diffusion-weighted monitoring of conservatively treated pyogenic brain abscesses: a marker for antibacterial treatment efficacy. AJNR Am J Neuroradiol 26:1296–1298 author reply 1300–1291PubMedGoogle Scholar
  4. 4.
    Dev R, Gupta RK, Poptani H et al (1998) Role of in vivo proton magnetic resonance spectroscopy in the diagnosis and management of brain abscesses. Neurosurgery 42:37–42PubMedCrossRefGoogle Scholar
  5. 5.
    Basoglu OK, Savas R, Kitis O (2002) Conventional and diffusion-weighted MR imaging of intracranial tuberculomas. A case report. Acta Radiol 43:560–562PubMedCrossRefGoogle Scholar
  6. 6.
    Gupta RK, Vatsal DK, Husain N et al (2001) Differentiation of tuberculous from pyogenic brain abscesses with in vivo proton MR spectroscopy and magnetization transfer MR imaging. AJNR Am J Neuroradiol 22:1503–1509PubMedGoogle Scholar
  7. 7.
    Luthra G, Parihar A, Nath K et al (2007) Comparative evaluation of fungal, tubercular, and pyogenic brain abscesses with conventional and diffusion MR imaging and proton MR spectroscopy. AJNR Am J Neuroradiol 28:1332–1338PubMedCrossRefGoogle Scholar
  8. 8.
    Gaviani P, Schwartz RB, Hedley-Whyte ET et al (2005) Diffusion-weighted imaging of fungal cerebral infection. AJNR Am J Neuroradiol 26:1115–1121PubMedGoogle Scholar
  9. 9.
    Chatterjee T, Gowardman JR, Goh TD (2003) Pneumococcal meningitis masquerading as subarachnoid haemorrhage. Med J Aust 178:505–507PubMedGoogle Scholar
  10. 10.
    Tung GA, Rogg JM (2003) Diffusion-weighted imaging of cerebritis. AJNR Am J Neuroradiol 24:1110–1113PubMedGoogle Scholar
  11. 11.
    Kuwahara S, Kawada M, Uga S (2001) Cryptococcal meningoencephalitis presenting with an unusual magnetic resonance imaging appearance — case report. Neurol Med Chir (Tokyo) 41:517–521CrossRefGoogle Scholar
  12. 12.
    Goyal M, Sharma A, Mishra NK, Gaikwad SB, Sharma MC (1997) Imaging appearance of pachymeningeal tuberculosis. AJR Am J Roentgenol 169:1421–1424PubMedGoogle Scholar
  13. 13.
    Erly WK, Bellon RJ, Seeger JF, Carmody RF (1999) MR imaging of acute coccidioidal meningitis. AJNR Am J Neuroradiol 20:509–514PubMedGoogle Scholar
  14. 14.
    Berkefeld J, Enzensberger W, Lanfermann H (1999) Cryptococcus meningoencephalitis in AIDS: parenchymal and meningeal forms. Neuroradiology 41:129–133PubMedCrossRefGoogle Scholar
  15. 15.
    Lipkin WI (1997) European consensus on viral encephalitis. Lancet 349:299–300PubMedCrossRefGoogle Scholar
  16. 16.
    Heiner L, Demaerel P (2003) Diffusion-weighted MR imaging findings in a patient with herpes simplex encephalitis. Eur J Radiol 45:195–198PubMedCrossRefGoogle Scholar
  17. 17.
    Agid R, Ducreux D, Halliday WC et al (2003) MR diffusion-weighted imaging in a case of West Nile virus encephalitis. Neurology 61:1821–1823PubMedGoogle Scholar
  18. 18.
    Lim CC, Lee WL, Leo YS et al (2003) Late clinical and magnetic resonance imaging follow up of Nipah virus infection. J Neurol Neurosurg Psychiatry 74:131–133PubMedCrossRefGoogle Scholar
  19. 19.
    Nolan MA, Craig ME, Lahra MM et al (2003) Survival after pulmonary edema due to enterovirus 71 encephalitis. Neurology 60:1651–1656PubMedGoogle Scholar
  20. 20.
    Chu JJ, Ng ML (2003) The mechanism of cell death during West Nile virus infection is dependent on initial infectious dose. J Gen Virol 84:3305–3314PubMedCrossRefGoogle Scholar
  21. 21.
    Zeller HG, Schuffenecker I (2004) West Nile virus: an overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas. Eur J Clin Microbiol Infect Dis 23:147–156PubMedCrossRefGoogle Scholar
  22. 22.
    Environmental Risk Analysis Program — Cornell University. Available at: http://environmentalrisk.cornell.edu/Google Scholar
  23. 23.
    Jeha LE, Sila CA, Lederman RJ et al (2003) West Nile virus infection: a new acute paralytic illness. Neurology 61:55–59PubMedGoogle Scholar
  24. 24.
    Kraushaar G, Patel R, Stoneham GW (2005) West Nile Virus: a case report with flaccid paralysis and cervical spinal cord: MR imaging findings. AJNR Am J Neuroradiol 26:26–29PubMedGoogle Scholar
  25. 25.
    Calli C, Ozel AA, Savas R et al (2002) Proton MR spectroscopy in the diagnosis and differentiation of encephalitis from other mimicking lesions. J Neuroradiol 29:23–28PubMedGoogle Scholar
  26. 26.
    Liberski PP, Gajdusek DC, Brown P (2002) How do neurons degenerate in prion diseases or transmissible spongiform encephalopathies (TSEs): neuronal autophagy revisited. Acta Neurobiol Exp (Wars) 62:141–147Google Scholar
  27. 27.
    Urbach H, Klisch J, Wolf HK et al (1998) MRI in sporadic Creutzfeldt-Jakob disease: correlation with clinical and neuropathological data. Neuroradiology 40:65–70PubMedCrossRefGoogle Scholar
  28. 28.
    Haik S, Dormont D, Faucheux BA et al (2002) Prion protein deposits match magnetic resonance imaging signal abnormalities in Creutzfeldt-Jakob disease. Ann Neurol 51:797–799PubMedCrossRefGoogle Scholar
  29. 29.
    Tschampa HJ, Murtz P, Flacke S et al (2003) Thalamic involvement in sporadic Creutzfeldt-Jakob disease: a diffusion-weighted MR imaging study. AJNR Am J Neuroradiol 24:908–915PubMedGoogle Scholar
  30. 30.
    Tschampa HJ, Zerr I, Urbach H (2007) Radiological assessment of Creutzfeldt-Jakob disease. Eur Radiol 17:1200–1211PubMedCrossRefGoogle Scholar
  31. 31.
    Martindale J, Geschwind MD, De Armond S et al (2003) Sporadic Creutzfeldt-Jakob disease mimicking variant Creutzfeldt-Jakob disease. Arch Neurol 60:767–770PubMedCrossRefGoogle Scholar
  32. 32.
    Pandya HG, Coley SC, Wilkinson ID, Griffiths PD (2003) Magnetic resonance spectroscopic abnormalities in sporadic and variant Creutzfeldt-Jakob disease. Clin Radiol 58:148–153PubMedCrossRefGoogle Scholar
  33. 33.
    Lim CC, Tan K, Verma KK et al (2004) Combined diffusion-weighted and spectroscopic MR imaging in Creutzfeldt-Jakob disease. Magn Reson Imaging 22:625–629PubMedCrossRefGoogle Scholar
  34. 34.
    Raffin LS, Bacheschi LA, Machado LR et al (2001) Diffusion-weighted MR imaging of cystic lesions of neurocysticercosis: a preliminary study. Arq Neuropsiquiatr 59:839–842PubMedGoogle Scholar
  35. 35.
    do Amaral LL, Ferreira RM, da Rocha AJ, Ferreira NP (2005) Neurocysticercosis: evaluation with advanced magnetic resonance techniques and atypical forms. Top Magn Reson Imaging 16:127–144PubMedCrossRefGoogle Scholar
  36. 36.
    Chang KH, Song IC, Kim SH et al (1998) In vivo single-voxel proton MR spectroscopy in intracranial cystic masses. AJNR Am J Neuroradiol 19:401–405PubMedGoogle Scholar
  37. 37.
    Pandit S, Lin A, Gahbauer H et al (2001) MR spectroscopy in neurocysticercosis. J Comput Assist Tomogr 25:950–952PubMedCrossRefGoogle Scholar
  38. 38.
    Camacho DL, Smith JK, Castillo M (2003) Differentiation of toxoplasmosis and lymphoma in AIDS patients by using apparent diffusion coefficients. AJNR Am J Neuroradiol 24:633–637PubMedGoogle Scholar
  39. 39.
    Schroeder PC, Post MJ, Oschatz E et al (2006) Analysis of the utility of diffusion-weighted MRI and apparent diffusion coefficient values in distinguishing central nervous system toxoplasmosis from lymphoma. Neuroradiology 48:715–720PubMedCrossRefGoogle Scholar
  40. 40.
    Ionita C, Wasay M, Balos L, Bakshi R (2004) MR imaging in toxoplasmosis encephalitis after bone marrow transplantation: paucity of enhancement despite fulminant disease. AJNR Am J Neuroradiol 25:270–273PubMedGoogle Scholar
  41. 41.
    Chaudhari AB, Singh A, Jindal S, Poon TP (1989) Haemorrhage in cerebral toxoplasmosis. A report on a patient with the acquired immunodeficiency syndrome. S Afr Med J 76:272–274PubMedGoogle Scholar
  42. 42.
    Bergui M, Bradac GB, Oguz KK et al (2004) Progressive multifocal leukoencephalopathy: diffusion-weighted imaging and pathological correlations. Neuroradiology 46:22–25PubMedCrossRefGoogle Scholar
  43. 43.
    da Pozzo S, Manara R, Tonello S, Carollo C (2006) Conventional and diffusion-weighted MRI in progressive multifocal leukoencephalopathy: new elements for identification and follow-up. Radiol Med (Torino) 111:971–977CrossRefPubMedGoogle Scholar
  44. 44.
    Iranzo A, Moreno A, Pujol J et al (1999) Proton magnetic resonance spectroscopy pattern of progressive multifocal leukoencephalopathy in AIDS. J Neurol Neurosurg Psychiatry 66:520–523PubMedCrossRefGoogle Scholar
  45. 45.
    Hurley RA, Ernst T, Khalili K et al (2003) Identification of HIV-associated progressive multifocal leukoencephalopathy: magnetic resonance imaging and spectroscopy. J Neuropsychiatry Clin Neurosci 15:1–6PubMedGoogle Scholar
  46. 46.
    Ho TL, Lee HJ, Lee KW, Chen WL (2005) Diffusion-weighted and conventional magnetic resonance imaging in cerebral cryptococcoma. Acta Radiol 46:411–414PubMedCrossRefGoogle Scholar
  47. 47.
    Kingsley PB, Shah TC, Woldenberg R (2006) Identification of diffuse and focal brain lesions by clinical magnetic resonance spectroscopy. NMR Biomed 19:435–462PubMedCrossRefGoogle Scholar
  48. 48.
    Avison MJ, Nath A, Berger JR (2002) Understanding pathogenesis and treatment of HIV dementia: a role for magnetic resonance? Trends Neurosci 25:468–473PubMedCrossRefGoogle Scholar
  49. 49.
    Yiannoutsos CT, Ernst T, Chang L et al (2004) Regional patterns of brain metabolites in AIDS dementia complex. Neuroimage 23:928–935PubMedCrossRefGoogle Scholar
  50. 50.
    Wu Y, Storey P, Cohen BA et al (2006) Diffusion alterations in corpus callosum of patients with HIV. AJNR Am J Neuroradiol 27:656–660PubMedGoogle Scholar
  51. 51.
    Bash S, Hathout GM, Cohen S (2001) Mesiotemporal T2-weighted hyperintensity: neurosyphilis mimicking herpes encephalitis. AJNR Am J Neuroradiol 22:314–316PubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2008

Authors and Affiliations

  • David Mikulis
    • 1
  • Stephan Wetzel
    • 2
  1. 1.Department of Medical ImagingThe University Health Network, The Toronto Western HospitalTorontoCanada
  2. 2.NeuroradiologieUniversitätsspitalBaselSwitzerland

Personalised recommendations